Form 4 for BOLT Bolt Biotherapeutics, Inc.
Accepted 2026-09-21 18:04:37 ET · period of report 2026-09-16 · accession 0001193125-26-396892 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 18:04 | 2026-06-05 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $3.88 | +509 | 1,924 | +36% | +$1,973 | |
| M | 2026-09-21 18:04 | 2026-09-16+ | BOLT | Nemec Sarah | Senior VP, Fin, PAO | S - Sale | $3.32 | -7,842 | 17.1K | -31% | -$26.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | P | A | 509 | $3.88 | 1,924 | D | — | — | (F1) These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c). |
| 2 | Common | Common Stock | 2026-09-16 | S | D | 843 | $3.77 | 24,081 | D | — | — | (F2) Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-09-17 | S | D | 2,922 | $3.32 | 21,159 | D | — | — | (F3) Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-09-18 | S | D | 4,077 | $3.24 | 17,082 | D | — | — | (F4) Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |